AI in Pharmacovigilance: A Catalyst for Progress or a Tradeoff to Human Potential?
In an environment as high stakes as pharmacovigilance, AI is not just about technology implementation; it's about balancing compliance, patient safety, and developmental breakthroughs. In this session, industry experts Dr. Siva Kumar Buddha of Amgen alongside TransPerfect's Poojah Singh will discuss how to integrate AI into existing processes in a strategic, fit-for-purpose approach. The two will discuss some of the challenges and risks associated with AI implementation, including governance frameworks, transparency requirements, and regulatory expectations. The conversation will also examine how the relationship between humans and machines is changing, and what teams should be thinking about now if they want to future-proof their safety operations. Join us for pragmatic, compliant strategies for using AI to improve safety operations without losing sight of what matters most: patient safety.
